Bellrose Capital EBITDA per Share
EBITDA per Share of Bellrose Capital (BELR) as of Nov 2, 2026.
Get this data via API
Financial Data API
EBITDA per Share
-USD
Last updated:
EBITDA per Share of Bellrose Capital is 2026 - USD. EBITDA per Share of Bellrose Capital was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Bellrose Capital Stock analysis
What does Bellrose Capital do? Founder and CEO Susan Johnson founded Deep Blue Inc in 2004 with the aim of developing powerful and effective technologies for the healthcare industry. The company is based in Los Angeles and employs over 100 employees worldwide.
The story of Deep Blue Inc began with the development of software for medical image processing. However, in recent years the company has evolved into a comprehensive provider of health technology, offering a wide range of products and services for the healthcare industry.
Deep Blue Inc operates in three main areas: medical image processing, clinical decision support, and digital health records. In the field of medical image processing, the company develops software solutions for the analysis of medical images, which assist doctors in diagnosing and monitoring diseases.
In the field of clinical decision support, Deep Blue Inc relies on artificial intelligence and machine learning to develop expert systems and decision support tools for medical professionals, with the aim of improving the quality of patient care.
Deep Blue Inc also offers a digital health record that allows for the management and sharing of health data. Doctors and patients can collectively manage data such as diagnoses, medication plans, and treatment outcomes.
Deep Blue Inc's products also include mobile apps for patients who want to monitor and manage their health. The company also provides training for medical personnel to ensure they can effectively utilize Deep Blue Inc's technologies and products.
Deep Blue Inc has formed partnerships with leading healthcare organizations and companies worldwide to implement and market its technologies and products. Partners include hospitals, healthcare systems, government institutions, and private companies.
Deep Blue Inc's business model is based on the development of innovative technologies for the healthcare industry and collaboration with partners and customers to implement and market these technologies. The company generates revenue through the sale of products and services, as well as through licensing fees and partnership agreements.
In recent years, Deep Blue Inc has received several awards and recognitions for its innovative technologies and services in the healthcare industry. The company is proud to contribute to improving patient care and lowering healthcare costs.
Overall, Deep Blue Inc has become a significant player in the health technology market. The company is committed to continuing to improve its technologies and products, and to collaborating with partners and customers worldwide to improve healthcare and reduce healthcare costs. Bellrose Capital is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Bellrose Capital stock
On Eulerpool you can find the complete historical development of EBITDA per Share Bellrose Capital since 2006 – with annual values, charts, and detailed analysis.
EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Bellrose Capital
All Key Metrics — Bellrose Capital
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth